Shaker A G, Fleming R, Jamieson M E, Yates R W, Coutts J R
University Department of Obstetrics and Gynaecology, Royal Infirmary, Glasgow, UK.
Hum Reprod. 1994 Nov;9(11):1997-8. doi: 10.1093/oxfordjournals.humrep.a138381.
Several authors have suggested that growth hormone may augment ovarian responses to follicle stimulating hormone in women (Homburg et al., Clin. Endocrinol., 29, 1988; Ibrahim et al., Fertil. Steril., 55, 1991), and that this effect may be mediated by insulin-like growth factor I (IGF-I) (Davoren and Hsueh, Endocrinology, 118, 1986). Menashe et al. (Hum. Reprod., 6, 1991) reported spontaneous pregnancies in women with a deficiency in growth hormone receptors and, consequently, low serum concentrations of IGF-I. In this report, we present the case of a patient with a rare syndrome first described by Oliver and Mcfarlane (Arch. Ophthalmol., 74, 1965). The patient was shown to be growth hormone deficient, with hypopituitarism as part of the syndrome. Adjuvant growth hormone did not influence her ovarian responses to exogenous gonadotrophins during assisted conception treatment, as reflected by the required total number of ampoules of human menopausal gonadotrophin, the number of developing follicles, the rate of follicular growth and the serum oestradiol concentrations.
几位作者提出,生长激素可能会增强女性卵巢对促卵泡激素的反应(洪堡等人,《临床内分泌学》,第29卷,1988年;易卜拉欣等人,《生育与不育》,第55卷,1991年),并且这种作用可能由胰岛素样生长因子I(IGF-I)介导(达沃伦和薛,《内分泌学》,第118卷,1986年)。梅纳谢等人(《人类生殖》,第6卷,1991年)报道,生长激素受体缺乏、因而血清IGF-I浓度较低的女性出现了自然受孕情况。在本报告中,我们介绍了一名患有奥利弗和麦克法兰于1965年首次描述的罕见综合征的患者。该患者被证明生长激素缺乏,垂体功能减退是该综合征的一部分。在辅助受孕治疗期间,辅助使用生长激素并未影响她的卵巢对外源性促性腺激素的反应,这体现在所需的人绝经期促性腺激素安瓿总数、发育卵泡数量、卵泡生长速率以及血清雌二醇浓度方面。